Polyclonal Endemicity of Carbapenemase-Producing Klebsiella pneumoniae in ICUs of a Greek Tertiary Care Hospital
- PMID: 35203752
- PMCID: PMC8868164
- DOI: 10.3390/antibiotics11020149
Polyclonal Endemicity of Carbapenemase-Producing Klebsiella pneumoniae in ICUs of a Greek Tertiary Care Hospital
Abstract
Carbapenemase-producing Klebsiella pneumoniae (CPKP) emerged in Greece in 2002 and became endemic thereafter. Driven by a notable variability in the phenotypic testing results for carbapenemase production in K. pneumoniae isolates from the intensive care units (ICUs) of our hospital, we performed a study to assess the molecular epidemiology of CPKP isolated between 2016 and 2019 using pulse-field gel electrophoresis (PFGE) including isolates recovered from 165 single patients. We investigated the molecular relatedness among strains recovered from rectal surveillance cultures and from respective subsequent infections due to CPKP in the same individual (48/165 cases). For the optimal interpretation of our findings, we carried out a systematic review regarding the clonality of CPKP isolated from clinical samples in ICUs in Europe. In our study, we identified 128 distinguishable pulsotypes and 17 clusters that indicated extended dissemination of CPKP within the hospital ICU setting throughout the study period. Among the clinical isolates, 122 harbored KPC genes (74%), 2 harbored KPC+NDM (1.2%), 38 harbored NDM (23%), 1 harbored NDM+OXA-48 (0.6%), 1 harbored NDM+VIM (0.6%) and 1 harbored the VIM (0.6%) gene. Multiple CPKP strains in our hospital have achieved sustained transmission. The polyclonal endemicity of CPKP presents a further threat for the selection of pathogens resistant to last-resort antimicrobial agents.
Keywords: KPC; Klebsiella pneumoniae; NDM; OXA-48; PFGE; VIM; carbapenemases; molecular epidemiology.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Falcone M., Russo A., Iacovelli A., Restuccia G., Ceccarelli G., Giordano A., Farcomeni A., Morelli A., Venditti M. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase–producing K. pneumoniae. Clin. Microbiol. Infect. 2016;22:444–450. doi: 10.1016/j.cmi.2016.01.016. - DOI - PubMed
-
- Palacios-Baena Z.R., Oteo J., Conejo C., Larrosa M.N., Bou G., Fernández-Martínez M., Oliver A., Zamorano L., Alba Rivera M., Bautista V. Comprehensive clinical and epide-miological assessment of colonisation andinfection due to carbapenemase-producing Enterobacteriaceae in Spain. J. Infect. 2016;72:152–160. doi: 10.1016/j.jinf.2015.10.008. - DOI - PubMed
-
- WHO Regional Office for Europe and European Centre for Disease Prevention and Control . Surveillance of Antimicrobial Resistance in Europe, 2020 Data. Executive Summary. WHO Regional Office for Europe; Copenhagen, Denmark: 2021.
-
- World Health Organization. Regional Office for Europe . Central Asian and European Surveillance of Antimicrobial Resistance: Annual Report 2020. WHO Regional Office for Europe; Copenhagen, Denmark: 2020.
LinkOut - more resources
Full Text Sources
Miscellaneous
